| scholarly article | Q13442814 |
| P2093 | author name string | Xin Zhang | |
| Dong Wang | |||
| Lijun Xu | |||
| Linlin Jin | |||
| Zhidong Li | |||
| Jingjing Cong | |||
| Xiaohu Zheng | |||
| Defeng Jiao | |||
| P2860 | cites work | Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells | Q24290869 |
| A second lineage of mammalian major histocompatibility complex class I genes | Q24561936 | ||
| Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma | Q84382998 | ||
| Cardiac glycosides exert anticancer effects by inducing immunogenic cell death | Q39311553 | ||
| 5-Fluorouracil and interferon-α immunochemotherapy enhances immunogenicity of murine pancreatic cancer through upregulation of NKG2D ligands and MHC class I. | Q39378905 | ||
| Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system. | Q39483235 | ||
| Human tumor cells killed by anthracyclines induce a tumor-specific immune response | Q39538516 | ||
| ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype | Q39903222 | ||
| Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity | Q40372686 | ||
| Molecular and cellular physiology of intracellular calcium stores | Q40674713 | ||
| Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy | Q40737932 | ||
| Manifold-assisted reverse transcription-PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients | Q40868477 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation. | Q46102063 | ||
| NKG2D-dependent anti-tumor effects of chemotherapy and radiotherapy against glioblastoma. | Q47433305 | ||
| Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. | Q47614555 | ||
| Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. | Q53585434 | ||
| Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. | Q54245592 | ||
| Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice | Q73038129 | ||
| A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death | Q24620548 | ||
| DAMPs from Cell Death to New Life | Q26782785 | ||
| Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy | Q27004011 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| Calreticulin exposure dictates the immunogenicity of cancer cell death | Q28280438 | ||
| Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells | Q28586586 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
| Up on the tightrope: natural killer cell activation and inhibition | Q29619175 | ||
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer | Q29620301 | ||
| Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer | Q33331108 | ||
| Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses | Q33620107 | ||
| Calreticulin: one protein, one gene, many functions. | Q33776572 | ||
| NK cell-based immunotherapy for malignant diseases | Q33827433 | ||
| DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown | Q34160434 | ||
| Immunogenic cell death and DAMPs in cancer therapy | Q34311701 | ||
| Regulation of ligands for the NKG2D activating receptor | Q34321457 | ||
| Natural killer cell memory in infection, inflammation and cancer | Q34510646 | ||
| Combinatorial strategies for the induction of immunogenic cell death | Q35535140 | ||
| CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells | Q35627666 | ||
| Natural endogenous adjuvants. | Q35988793 | ||
| Immunobiology of human NKG2D and its ligands | Q36331613 | ||
| The determinants of tumour immunogenicity | Q36555524 | ||
| Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma | Q36883666 | ||
| Molecular characteristics of immunogenic cancer cell death. | Q37002804 | ||
| NKG2D ligands in tumor immunity | Q37287179 | ||
| Targeting the immune system in cancer | Q37387474 | ||
| Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity | Q37509338 | ||
| Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments | Q38119845 | ||
| Cancer immunogenicity, danger signals, and DAMPs: what, when, and how? | Q38125424 | ||
| Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer | Q38829403 | ||
| High hydrostatic pressure induces immunogenic cell death in human tumor cells | Q39026704 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 331 | |
| P577 | publication date | 2020-02-25 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer | |
| P478 | volume | 11 |
Search more.